Nabil Hafez

Nabil Hafez is the CEO of Genomate Health, a company focused on integrating artificial intelligence into cancer treatment. With a background that includes significant contributions to the Human Genome Project, he has been instrumental in advancing personalized medicine. Under his leadership, Genomate aims to enhance treatment options for cancer patients by leveraging AI to create tailored therapeutic plans, marking a significant milestone in the intersection of healthcare and technology.